1 Healthcare Stock to Buy Hand Over Fist Going Into 2024
A couple of years ago many companies took an untraditional route to the public markets. An investment vehicle called a special purpose acquisition company (SPAC) saw a resurgence in activity. SPACs are more colloquially referred to as "blank check companies," and represent an alternative way to go about an initial public offering (IPO).
Unfortunately for investors, many SPACs underperformed as the businesses were still highly speculative. As a result, sentiment around SPAC stocks soured as investors looked to recoup capital and deploy it elsewhere.
With that said, one SPAC has emerged on my radar as a potentially lucrative opportunity. A telemedicine company called Hims & Hers Health (NYSE: HIMS) is trading more than 60% below all-time highs. My thinking is that as investors moved away from SPAC stocks in droves, Hims & Hers Health was forgotten. Let's dig into the company and analyze its performance. You might find that its growth prospects and budding operation deserve a little more attention.
Source Fool.com
